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Abstract
Introduction: Rheumatoid arthritis (RA) is a multifactorial autoimmune disease in which genetic and environmental
factors interact in the etiology. In this study, we investigated whether smoking and HLA-DRB1 shared-epitope (SE)
alleles interact differently in the development of the two major subgroups of rheumatoid arthritis (RA), anti-
citrullinated proteins antibody (ACPA)-positive and ACPA-negative disease, in a multiethnic population of Asian
descent.
Methods: A case-control study comprising early diagnosed RA cases was carried out in Malaysia between 2005
and 2009. In total, 1,076 cases and 1,612 matched controls participated in the study. High-resolution HLA-DRB1
genotyping was performed for shared-epitope (SE) alleles. All participants answered a questionnaire on a broad
range of issues, including smoking habits. The odds ratio (OR) of developing ACPA-positive and ACPA-negative
disease was calculated for smoking and the presence of any SE alleles separately. Potential interaction between
smoking history (defined as “ever” and “never” smoking) and HLA-DRB1 SE alleles also was calculated.
Results: In our multiethnic study, both the SE alleles and smoking were associated with an increased risk of
developing ACPA-positive RA (OR SE alleles, 4.7; 95% confidence interval (CI), 3.6 to 6.2; OR smoking, 4.1; 95% CI,
1.9 to 9.2). SE-positive smokers had an odds ratio of ACPA-positive RA of 25.6 (95% CI, 10.4 to 63.4), compared with
SE-negative never-smokers. The interaction between smoking and SE alleles was significant (attributable proportion
due to interaction (AP) was 0.7 (95% CI, 0.5 to 1.0)). The HLA-DRB1*04:05 SE allele, which is common in Asian
populations, but not among Caucasians, was associated with an increased risk of ACPA-positive RA, and this allele
also showed signs of interaction with smoking (AP, 0.4; 95% CI, -0.1 to 0.9). Neither smoking nor SE alleles nor their
combination was associated with an increased risk of ACPA-negative RA.
Conclusions: The risk of developing ACPA-positive RA is associated with a strong gene-environment interaction
between smoking and HLA-DRB1 SE alleles in a Malaysian multiethnic population of Asian descent. This interaction
seems to apply also between smoking and the specific HLA-DRB1*04:05 SE allele, which is common in Asian
populations but not in Caucasians.
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Introduction
Rheumatoid arthritis (RA) is a multifactorial autoim-
mune disease in which genetic and environmental fac-
tors interact in the etiology of the disease [1,2]. The
strongest gene association is considered to be within the
human leukocyte antigen (HLA) region, particularly the
HLA-DRB1 genes. Multiple HLA-DRB1 alleles encoding
the shared epitope (SE) at amino acid positions 70 to 74
in the third hypervariable region of the DRb1 molecules
are associated with a higher risk for RA [3].
Relatively little is known about environmental factors
that may contribute to the disease, except smoking,
which is the main environmental factor that has consis-
tently been related to an increased risk of RA [4-11].
Recent data revealed a strong gene-environment interac-
tion between smoking and SE alleles in the risk of
ACPA-positive RA. However, the majority of studies
undertaken so far have focused on the Caucasian popula-
tions, with consistent findings [5-8,10-13]. In contrast, a
cross-sectional study of African Americans with early RA
did not find an association between smoking and ACPA-
positive RA [14]. A study of an Asian population on pre-
valent RA cases demonstrated that the combination of
SE alleles and smoking was associated with risk of RA,
regardless of ACPA status [4]. A gene-environment inter-
action between smoking and SE alleles was, however,
observed only for ACPA-positive RA in this study.
In the Malaysian Epidemiological Investigation of
Rheumatoid Arthritis (MyEIRA) case-control study, we
recently reported that HLA-DRB1 SE alleles were consis-
tently associated with ACPA-positive RA in three Asian
ethnic populations [15]. Furthermore, our group also
demonstrated that smoking is associated with RA devel-
opment and that this effect is restricted to the ACPA-
positive RA subset [16]. However, the question whether
the HLA-DRB1 SE alleles and smoking interacts in pro-
viding an increased risks for ACPA-positive RA remains
to be answered in our non-Caucasian population. This
question is of particular relevance, as the occurrence of
different HLA-DRB1 SE alleles is different between Asian
and Caucasian populations.
In the present study, we used the first large Asian
case-control study performed in Malaysia involving early
RA to investigate the interaction between smoking and
HLA-DRB1 SE alleles (including those that are rare in
Caucasian populations) regarding risk of disease.
Materials and methods
Study design
The source of data for our investigation was the MyEIRA
case-control study, in which the subjects were individuals
aged 18 to 70 years in Peninsular Malaysia. The recruit-
ment period for cases and controls was between August
2005 and December 2009.
Identification of cases and controls
The details of the MyEIRA study have been described
elsewhere [16]. In brief, patients with early RA were iden-
tified from nine centers throughout Peninsular Malaysia.
All cases were diagnosed by rheumatologists according to
the 1987 revised American College of Rheumatology cri-
teria [17]. The clinical and radiographic data were
recorded in a binary fashion (present or absent). For each
case, a population control was randomly selected
matched by age, sex, and residential area. In addition,
hospital-based controls were recruited in the first 2 years
of the study period. These were selected among hospital
staff, people who accompanied patients, and patients
without any underlying autoimmune diseases. Participa-
tion in the study was voluntary, and if an eligible control
decided not to participate, another control was selected
by using the same procedure. Written consent was
obtained from all participants. The Medical Research and
Ethnics Committee, Ministry of Health, Malaysia,
approved the study.
Data collection and blood sampling
Information about environmental exposures was collected
from cases and controls by means of an identical question-
naire used in a face-to-face interview by well-trained inter-
viewers. Cases and controls were also asked to provide a
blood sample. Of the 1,166 identified early RA cases, 1,076
(92%) completed a questionnaire. In total, 2,112 controls
were identified in the study, and the participation propor-
tion was 76%, resulting in 1,612 controls available for ana-
lysis. Sera for serologic analysis and cells for DNA
preparation were obtained from all the participating
subjects.
DNA extraction and HLA-DRB1 genotyping
White cells were separated by using Ficoll Hypaque, and
the DNA was extracted by using the QIAamp DNA
Blood Mini Kit from Qiagen (Hilden, Germany). All
DNA was stored at -20°C until tested. HLA-DRB1 two-
digit and 4-digit genotyping were performed by the PCR-
SSO method described elsewhere [15]. The overall geno-
typing success rate was 99.9%. DNA samples from two
RA cases were of poor quality in genotyping and there-
fore excluded from the statistical evaluation. The HLA-
DRB1 shared epitope (SE) alleles group was defined by
HLA-DRB1*01:01, *01:02, *01:07, *04:01, *04:04, *04:05,
*04:08, *04:10, *10:01, and *10:03. More than 95% of the
HLA-DRB1*10 subtypes were HLA-DRB1*10:01. A pre-
ponderance of HLA-DRB1 SE alleles occurred in the RA
cases compared with controls (40% versus 16%). Only 46
(4.4%) of 1,054 RA patients carried two copies of HLA-
DRB1 SE alleles. Thus, we decided to limit the analysis to
investigate the influence from any SE allele (either one or
two copies of SE alleles) on RA risk.
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Autoantibody measurements
Anti-citrullinated peptide antibody (ACPA) was quanti-
fied by using the anti-CCP ELISA kits (Immunoscan-
RA, Malmö, Sweden) for all subjects [15]. An antibody
level ≥25 AU/ml was regarded as ACPA positive. For
the determination of IgM and IgG rheumatoid factors,
we used the ELISA kits of Immuno-Biological Labora-
tories, Hamburg, Germany. An antibody level > 15 IU/
ml was defined as positive.
Definition of smoking status
Cases and controls were classified as “ever-smokers” and
“never-smokers,” according to their reported smoking
habits. In brief, ever-smokers were defined as those who
smoked before or during the index year (the time point
at which RA symptoms started and the corresponding
time point among the matched controls), as described
previously [16]. Never-smokers are those who had never
smoked before or during the index year.
Statistical analysis
In the analyses, data from cases and their matched con-
trols were used. Twenty cases and 196 controls lacked
information from a matched control/case, and therefore
in total, 1,056 cases and 1,416 controls (1,056 matched
population controls and 360 matched hospital controls)
were retained in the analyses. Smoking history was
obtained from 1,006 patients with RA (95.3%) and from
1,325 control subjects (93.6%). Of these, 79 of the cases
had ever smoked (70 men and nine women), and 65 of
the control subjects were ever-smokers (60 men and five
women) (Table 1).
The odds ratio (OR) and 95% confidence interval (95%
CI) of developing ACPA-positive RA, ACPA-negative
RA, and RA in total, associated with smoking habits and
the presence of SE alleles, were calculated by using con-
ditional logistic regression. Never-smokers without SE-
alleles were used as reference group. HLA-DRB1*04:05
is the most common allele within the HLA-DRB1*04
group in our Malaysian population (the allelic frequency
was 15.5% among cases and 5.7% among controls). Sub-
sequently, we performed additional analyses by stratify-
ing the SE-positive individuals into two groups: the
HLA-DRB1*04:05 group and the non-HLA-DRB1*04:05
group (defined by HLA-DRB1*01:01, *01:02, *01:07,
*04:01, *04:04, *04:08, *04:10, *10:01, and *10:03). Cases
(n = 13) and controls (n = 1) carrying HLA-DRB1*04:05
as first allele and a non-HLA-DRB1*04:05 SE as second
allele were not included in this analysis.
Interaction between smoking habits and the presence
of SE alleles was evaluated as a departure from the addi-
tivity of effects and was estimated by calculating the
attributable proportion due to interaction (AP) together
with the 95% CI [18].
Potential confounding factors (that is, formal educa-
tional level (categorized as no formal education, primary
education, secondary education or college/university))
and ethnicity (categorized as Malay, Chinese, Indian,
and Others), were adjusted for in all analyses. The SAS
software, version 9.2 (SAS Institute, Cary, NC, USA)
was used for computations.
Results
Characteristics of the subjects
In this report, the 2,110 participants (n = 905 RA cases
and 1,205 controls) were women, and 362 were men
(n = 151 RA cases and n = 211 controls). The median
duration of time from disease onset to inclusion in the
study was 1 year, with an interquartile range (IQR) of
2 years for both men and women. Radiographic data
were recorded as presence or absence of hand-joint ero-
sions. In total, 974 radiographic erosion data were avail-
able in the present study. Of these, 169 (17.4%) of 974
patients had erosive RA. Extraarticular features were
present in 114 (11.7%) patients with RA: 52 (5.3%)
patients had sicca syndrome; 28 (2.9%) patients had lung
fibrosis; 19 (2.0%) patients had rheumatoid nodules; 14
(1.4%) patients had secondary Sjögren syndrome; and
one patient had vasculitis. Ever-smoking was more fre-
quent in men for both cases (48%) and controls (28%),
as compared with women (1% among cases and 0.4%
among controls). In total, 64% of the cases were ACPA
positive, and 40% of the cases were carriers of SE alleles.
Of the 680 ACPA-positive RA cases, 344 (51%) indivi-
duals carried SE alleles; 51.2% and 51.7% of RA patients
were IgM RF-positive and IgG RF-positive, respectively.
The distribution of ethnic groups (Malays, Chinese,
Indians, and other subethnicities) is presented in Table
1. Men were slightly older than women. The proportion
with higher education was higher among the controls
than the cases (74% versus 66%, data not shown).
Smoking and the risk of ACPA-positive/-negative RA
The odds ratio of developing ACPA-positive RA was 4.1
(95% CI, 1.9 to 9.2), among ever-smokers compared with
never-smokers (Table 2). This increased risk was seen in
both men and women, but the number of smokers among
women was small. No association was found between
smoking and the risk of developing ACPA-negative RA
(OR = 0.7; 95% CI, 0.3 to 2.0).
HLA-DRB1 SE alleles and the risk of ACPA-positive/
negative RA
Carriers of HLA-DRB1 SE alleles had an increased risk of
developing ACPA-positive RA (OR = 4.7; 95% CI, 3.6 to
6.2), compared with those without SE alleles (Table 3).
When the HLA-DRB1*04:05 allele group was analyzed
separately, this subgroup also showed an association with
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an increased risk of ACPA-positive RA (OR = 6.5; 95%
CI, 4.9 to 8.7). No increased risk of ACPA-negative RA
was found in individuals carrying any SE allele (OR = 1.2;
95% CI, 0.8 to 1.7), or the HLA-DRB1*04:05 allele when
this was investigated separately (OR = 1.2; 95% CI, 0.8
to 1.9).
Interaction between smoking and SE alleles in relation to
ACPA-positive/-negative RA
We observed an increased risk of ACPA-positive RA
among ever-smokers without SE alleles (OR = 3.1; 95%
CI, 1.7 to 5.7), compared with never-smokers without SE
alleles (Table 4). In never-smokers with SE alleles, the
OR for ACPA-positive RA was 4.4 (95% CI, 3.5 to 5.6);
compared with never-smokers without the SE allele. A
dramatically increased risk for ACPA-positive RA was
seen in individuals who were both smokers and HLA-
DRB1 SE positive (OR = 25.6; 95% CI, 10.4 to 63.4), and
here we also observed a statistically significant gene-envir-
onment interaction between smoking and the HLA-DRB1
SE (AP = 0.7; 95% CI, 0.5 to 1.0; Figure 1). The combina-
tion of smoking and the HLA-DRB1*04:05 SE allele was
also associated with an increased risk of ACPA-positive
RA (OR = 12.9; 95% CI, 4.7 to 35.3; Table 5), and signs of














Age, mean (SD) years 47.7 (11.5) 47.1 (11.4) 50.1 (11.9) 49.8 (11.9) 47.3 (11.4) 46.7 (11.3)
Smoking status
Never-smoker, n (%) 927 (88) 1,260 (89) 61 (40) 101 (48) 866 (96) 1159 (96.2)
Ever-smoker, n (%) 79 (7) 65 (5) 70 (46) 60 (28) 9 (1) 5 (0.4)
Information missing on smoking, n
(%)
50 (5) 91 (6) 20 (14) 50 (24) 30 (3) 41 (3.4)
Ethnic group
Malay 441 (42) 893 (63) 66 (44) 126 (60) 375 (41) 767 (64)
Chinese 217 (20) 183 (13) 36 (24) 31 (15) 181 (20) 152 (13)
Indian 323 (31) 253 (18) 37 (25) 43 (20) 286 (32) 210 (17)
Others 75 (7) 87 (6) 12 (8) 11 (5) 63 (7) 76 (6)
ACPA status
ACPA-positive RA, n (%) 680 (64) 32 (2) 104 (69) 5 (2) 576 (64) 27 (2)
ACPA-negative RA, n (%) 376 (36) 1,383 (98) 47 (31) 206 (98) 329 (36) 1,177 (98)
Presence of SE alleles
None SE alleles, n (%) 629 (60) 1,183 (84) 83 (55) 181 (86) 546 (60) 1,002 (83)
Any SE alleles, n (%) 425 (40) 233 (16) 68 (45) 30 (14) 357 (39) 203 (17)
ACPA, anti-citrullinated peptide antibody; DNA, deoxyribonucleic acid; MyEIRA, Malaysian Epidemiological Investigation of rheumatoid arthritis; RA, rheumatoid
arthritis; SD, standard deviation; SE, shared epitope. The “any SE alleles” group was defined by the presence of either one or two HLA-DRB1*01:01, *01:02, *01:07,
*04:01, *04:04, *04:05, *04:08, *04:10, *10:01, and/or *10:03 SE alleles.
Table 2 Odds ratios of developing RA overall, ACPA-positive RA, and ACPA-negative RA among ever-smokers
compared with never-smokers in MyEIRA
All Men Women
Ca/Co OR (95% CI) Ca/Co OR (95% CI) Ca/Co OR (95% CI)
All RA
Never-smokers 927/1,260 1.0 61/101 1.0 866/1,159 1.0
Ever-smokers 79/65 2.2 (1.2 to 3.9) 70/60 2.0 (1.0 to 4.0) 9/5 1.9 (0.9 to 6.1)
ACPA-positive RA
Never-smokers 577/1,260 1.0 33/101 1.0 544/1,159 1.0
Ever-smokers 64/65 4.1 (1.9 to 9.2) 56/60 3.5 (1.3 to 9.4) 8/5 3.6 (0.7 to 18.4)
ACPA-negative RA
Never-smokers 350/1,260 1.0 28/101 1.0 322/1,159 1.0
Ever-smokers 15/65 0.7 (0.3 to 2.0) 14/60 0.8 (0.2 to 3.4) 1/5 0.5 (0.05 to 4.7)
ACPA, anti-cyclic citrullinated proteins antibody; Ca/Co is number of exposed cases/number of exposed controls; MyEIRA, Malaysian Epidemiological Investigation
of Rheumatoid Arthritis; OR (95% CI), odds ratio and 95% confidence interval, adjusted for ethnicity and formal education by using conditional logistic regression;
RA, rheumatoid arthritis.
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interaction were seen, albeit statistically insignificant (AP =
0.4; 95% CI, -0.1 to 0.9).
The same pattern of interaction was observed when RF
(IgM and IgG) was used for the subdivision of RA cases:
HLA-DRB1 SE alleles were found to interact significantly
with smoking only for RF-positive RA (for IgM RF, OR =
23.5; 95% CI, 9.5 to 57.8; AP = 0.7, 95% CI, 0.6 to 0.9; and
for IgG RF, OR = 19.4; 95% CI, 7.9 to 47.8; AP = 0.7, 95%
CI, 0.5 to 0.9), but not for the RF-negative RA subgroup
(data not shown).
We also separately analyzed data only from the largest
ethnic group in our study, the Malays. Smokers carrying
SE alleles had a remarkably increased risk of ACPA-posi-
tive RA (OR = 32.0; 95% CI, 8.7 to 117.9; AP = 0.8; 95%
CI, 0.5 to 1.1), compared with SE-negative never-smo-
kers. The results for the two other major ethnic groups,
Chinese and Indians, showed the same pattern but,
because of the small number of observations, the preci-
sion was very low.
Discussion
Two principal findings are presented in this case-control
study. First, both smoking and the SE alleles were asso-
ciated mainly with an increased risk of ACPA-positive
RA. Second, we demonstrated a strong gene-environ-
ment interaction between smoking and SE alleles, which
was restricted to only ACPA-positive RA in a multieth-
nic Malaysian population of Asian descent. Interestingly,
this interaction seems to appear also between smoking
and the SE allele HLA-DRB1*04:05, common in Asian
but not among Caucasian subjects. Thus, our data
extend previous results based on the Caucasian popula-
tions [6,7,10,11,13] to be observed also in an Asian
population.
Table 3 Odds ratios of developing RA overall, ACPA-positive RA, or ACPA-negative RA among carriers of SE alleles
compared with individuals without SE alleles in MyEIRA
All Men Women
Ca/Co OR (95% CI) Ca/Co OR (95% CI) Ca/Co OR (95% CI)
All RA
No SE allele 629/1,183 1.0 83/181 1.0 546/1,002 1.0
Any SE alleles 425/233 3.0 (2.4 to 3.7) 68/30 4.5 (2.6 to 7.8) 357/203 2.8 (2.3 to 3.5)
ACPA-positive RA
No SE allele 334/1,183 1.0 45/181 1.0 289/1,002 1.0
Any SE alleles 345/233 4.7 (3.6 to 6.2) 59/30 8.0 (3.7 to 17.2) 286/203 4.3 (3.2 to 5.7)
HLA-DRB1*04:05 158/86 6.5 (4.9 to 8.7) 29/16 7.3 (3.3 to 14.6) 129/70 6.4 (4.6 to 8.8)
Non-HLA-DRB1*04:05 SE alleles 187/147 4.5 (3.5 to 5.8) 30/14 8.6 (4.2 to 17.6) 157/133 4.1 (3.1 to 5.3)
ACPA-negative RA
No SE allele 295/1,183 1.0 38/181 1.0 257/1,002 1.0
Any SE alleles 80/233 1.2 (0.8 to 1.7) 9/30 1.5 (0.6 to 3.9) 71/203 1.2 (0.8 to 1.7
HLA-DRB1*04:05 26/86 1.2 (0.8 to 1.9) 4/16 1.2 (0.4 to 3.8) 22/70 1.2 (0.7 to 2.0)
Non-HLA-DRB1*04:05 SE alleles 54/147 1.5 (1.1 to 2.1) 5/14 1.7 (0.6 to 5.0) 49/133 1.4 (1.0 to 2.0)
ACPA, anti-cyclic citrullinated proteins antibody; Ca/Co, the number of exposed cases/number of exposed controls; MyEIRA, Malaysian Epidemiological
Investigation of Rheumatoid Arthritis; OR (95% CI), odds ratio and 95% confidence interval, adjusted for ethnicity and formal education by using conditional
logistic regression; RA, rheumatoid arthritis. The “any SE alleles group” was defined by the presence of either one or two HLA-DRB1*01:01, *01:02, *01:07, *04:01,
*04:04, *04:05, *04:08, *04:10, *10:01, and/or *10:03. The “HLA-DRB1*04:05 group” was defined by the presence of either one or two HLA-DRB1*04:05 allele.
Table 4 Odds ratios of developing ACPA-positive RA and ACPA-negative RA in subjects exposed to different
combinations of smoking and SE alleles compared with never-smokers without SE alleles in MyEIRA
No SE Any SE
Ca/Co OR (95% CI)* Ca/Co OR (95% CI)*
ACPA-positive RA
Never-smokers 266/986 1.0 264/202 4.4 (3.5 to 5.6)
Ever-smokers 30/52 3.1 (1.7 to 5.7) 33/8 25.6 (10.4 to 63.4)
AP 0.7 (0.5 to 1.0)
ACPA-negative RA
Never-smokers 254/986 1.0 65/202 1.1 (0.7 to 1.7)
Ever-smokers 10/52 0.6 (0.2 to 2.0) 3/8 0.8 (0.1 to 4.8)
ACPA, anti-cyclic citrullinated proteins antibody; AP, attributable proportion due to interaction; Ca/Co, number of exposed cases/number of exposed controls;
MyEIRA, Malaysian Epidemiological Investigation of Rheumatoid Arthritis; OR (95% CI), odds ratio and 95% confidence interval, adjusted for ethnicity, formal
education, age, sex, residential area, *calculated by means of unconditional logistic regression to increase power; RA, rheumatoid arthritis; SE, shared epitope.
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Our current study was designed as a case-control study
with primarily early RA cases with the aim of investigating
the impact of environmental, life-style, and genetic factors
on the development of RA in an Asian population. The
study was performed with the Swedish EIRA study as pro-
totype [11] and has the advantage of being a large case-
control study involving RA cases with short disease dura-
tion. A possible disadvantage with a case-control study
using retrospectively collected data is the risk of recall
bias, which occurs if the cases recall their previous expo-
sure differently from the controls. Therefore, we included
only cases with short disease duration to facilitate more-
accurate information about their smoking habits before
disease onset. Furthermore, in a previous report on smok-
ing and the risk of RA, we performed a separate analysis
on cases with symptom durations of less than 1 year to
investigate possible recall bias [16]. In that analysis, ever-
smoking was associated with an increased risk of ACPA-
positive RA, which was in accordance with the results for
which information from all cases was used.
In this report, we included both hospital- and popula-
tion-based controls. Hospital controls might introduce
selection bias if they do not reflect the smoking habits
in the study base that generated the cases in our study.
To elucidate this potential bias, we conducted separate
analyses based on hospital and population controls,
respectively. The results between these analyses were
consistent, and thus we decided to merge the two con-












(a) ACPA-positive RA     (b) ACPA-negative RA 
OR 
Figure 1 Odds ratios of developing ACPA-positive and ACPA-negative rheumatoid arthritis (RA) for different combinations of smoking
and SE alleles. The odds ratios of developing (a) ACPA-positive RA and (b) ACPA-negative RA were compared with those who never smoked
and have no SE alleles.
Table 5 Odds ratios for developing ACPA-positive RA and ACPA-negative RA in subjects exposed to different
combinations of smoking and presence of HLA-DRB1*04:05 or non-HLA-DRB1*04:05 SE alleles, compared with never-
smokers without SE alleles in MyEIRA
No SE alleles HLA-DRB1*04:05 SE allelesab Any non-HLA-DRB1*04:05 SE allelesc
Ca/Co OR (95% CI) Ca/Co OR (95% CI) Ca/Co OR (95% CI)
ACPA-positive RA
Never-smokers 266/986 1.0 102/71 5.4 (3.8 to 7.5) 152/130 3.1 (2.4 to 4.0)
Ever-smokers 30/52 3.1 (1.7 to 5.7) 16/7 12.9 (4.7 to 35.3) 15/1 82.4 (10.3 to 656.9)
AP 0.4 (-0.1 to 0.9) 0.9 (0.8 to 1.1)
ACPA-negative RA
Never-smokers 254/986 1.0 20/71 1.1 (0.7 to 1.8) 44/130 1.3 (0.9 to 1.9)
Ever-smokers 10/52 0.6 (0.2 to 2.0) 1/7 0.6 (0.1 to 4.8) 2/1 8.1 (0.7 to 93.0)
ACPA, anti-cyclic citrullinated proteins antibody; AP, attributable proportion due to interaction; Ca/Co, number of exposed cases/number of exposed controls;
MyEIRA, Malaysian Epidemiological Investigation of Rheumatoid Arthritis; OR (95% CI), odds ratio and 95% confidence interval, adjusted for ethnicity, formal
education, age, sex, residential area, calculated by means of unconditional logistic regression to increase power; RA, rheumatoid arthritis; SE, shared epitope. a
HLA-DRB1*04:05 group was defined by the presence of either one or two copies of HLA-DRB1*04:05 allele. bIndividuals with first allele of HLA-DRB1*04:05 and
second allele of a non-HLA-DRB1*04:05 SE (that is, HLA-DRB1*04:05/non-HLA-DRB1*04:05 SE) were not included in the interaction analysis (cases, 13; control, 1).
cAny non-HLA-DRB1*04:05 SE alleles group was defined by the presence of either one or two copies HLA-DRB1*01:01, *01:02, *01:07, *04:01, *04:04, *04:08, *04:10,
*10:01, and *10:03 alleles.
Too et al. Arthritis Research & Therapy 2012, 14:R89
http://arthritis-research.com/content/14/2/R89
Page 6 of 9
We previously demonstrated a profound interaction
between smoking and SE alleles concerning risk of
developing ACPA-positive RA in the Swedish EIRA
population-based case-control study. We also provided
evidence that cigarette smoking may induce citrullina-
tion in cells from the lungs [11]. Subsequent studies
replicated and extended these findings, although mainly
among Caucasians [5,6,8-10,19]. Similarly, smoking and
SE alleles were also associated with the risk of develop-
ing RA, irrespective of RF or ACPA status in a Korean
case-control study based on prevalent RA cases. How-
ever, interaction between smoking and SE alleles was
statistically significant only for autoantibody-positive RA
[4].
The genetic heterogeneity in our multiethnic study
population is a major concern. We therefore performed
stratified analyses by ethnicity, but the number of obser-
vations was too small to permit a meaningful analysis,
except for the Malays. However, all the ethnic groups
were showing similar trends toward the risk developing
RA. Therefore, we decided to analyze them together to
raise the statistical power for analyzing the exposures in
question. As a result, we demonstrated a strong gene-
environment interaction between smoking and SE alleles
in ACPA-positive RA. These results are in accordance
with those of other studies [10,11,13]. Nevertheless, these
data are also in line with our previously reported hypoth-
esis that cigarette smoking modulates the loss of toler-
ance to citrullinated autontigens occurring in SE-positive
individuals [11].
Intriguingly, comparisons of populations with different
genetic backgrounds but similar environmental exposure
(smoking) can shed light on the general influence of non-
genetic factors. Some SE alleles, like HLA-DRB1*04:05
and HLA-DRB1*10:01, are common in Asia [15] but not
in Caucasian populations, in which instead HLA-
DRB1*04:01 and HLA-DRB1*04:04 are common. An arti-
cle recently published by our group demonstrated that,
regardless of fine specificity, all HLA-DRB1 SE alleles
strongly interacted with smoking in the development of
ACPA-positive RA in the Swedish Caucasian population
[7]. The HLA-DRB1*04:05 allele is the most common SE-
encoding HLA-DRB1*04 subtype associated with RA
reported in Asian populations, but is rare in Caucasian
populations [15,20-22]. However, we are not aware of
any published studies on interaction between smoking
and distinct SE alleles in the development of RA defined
by ACPA-subsets in multiethnic Asian populations. We
observed that ever-smokers carrying the HLA-
DRB1*04:05 allele had a 12.9-fold increased risk of
ACPA-positive RA, and that signs of interaction were
found between smoking and HLA-DRB1*04:05, although
the interaction was not statistically significant (AP = 0.4;
95% CI, -0.1 to -0.9). Additional studies are needed for
replication of these findings in other populations.
Several studies have reported positive interaction
between SE and the cumulative dose of smoking and
RA risk [9,19]. In this report, that kind of interaction
analysis was not possible to perform because of small
number of heavy smokers with SE alleles.
Finally, in the Swedish EIRA study, we found that
smoking was responsible for approximately 35% of the
ACPA-positive RA cases [23]. Although the female
smoking prevalence was much lower in the present
study, we estimated that smoking was responsible for
approximately 8% of the ACPA-positive RA cases (1%
for women, 45% for men). Because an increasing smok-
ing trend is found in women in Asia, public health mea-
sures to prevent smoking are of importance.
Conclusions
In conclusion, our findings indicate a gene-environment
interaction between smoking and SE alleles in the develop-
ment of ACPA-positive RA, but not in the development of
ACPA-negative RA in a multiethnic population of Asian
descent. This interaction also seems to apply between
smoking and an HLA-DRB1 SE allele (HLA-DRB1*04:05)
common in Asian populations but not in Caucasians. Our
data are in accordance with previous findings among Cau-
casians and thus extend the basis for RA pathogenesis
hypothesis involving genetic and environmental factors.
Taken together, these findings may provide a new insight
into the interplay between two major RA-susceptible risk
factors (smoking and SE alleles) along one or more biolo-
gic pathways, which are common for the RA disease itself
regardless of population origins.
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